Swiss drug maker Novartis on Monday presented the final-stage trial of Signifor long-acting release (LAR) therapy and expressed confidence that it can do wonders in treating patients with the endocrine disorder acromegaly than existing therapies. The clinical trial was presented at the 16th European Congress of Endocrinology3. The study, conducted by Novartis, showed that patients who took … [Read more...]
You are here: Home / Archives for LAR therapy